File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

TitleDataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
Authors
KeywordsDataset
Gestational trophoblastic neoplasia
Measurement
Protocol
Staging
Issue Date24-Oct-2022
PublisherLippincott, Williams & Wilkins
Citation
International Journal of Gynecological Pathology, 2022, v. 41, n. 6, p. S34-S43 How to Cite?
Abstract

Comprehensive pathology reporting of cancers is important for patient management, tumor staging, and prognostication. Standardized cancer datasets are essential in guiding pathology reporting in a consistent and concise manner and this facilitates effective global cancer information exchange and comparison. The International Collaboration on Cancer Reporting (ICCR) is an alliance of several national and international pathology societies in many countries as well as bodies which are involved in tumor classification and staging. One function of the ICCR is to develop evidence-based, standardized reporting datasets for each cancer site. Herein, we report the development of an evidence-based cancer dataset by an ICCR panel of international experts for the reporting of primary uterine gestational trophoblastic neoplasia. We present the core elements that should be included and noncore elements that are recommended for inclusion in pathology reports. Lists of the response values are provided for each element, along with explanatory commentaries. The dataset also discusses controversial issues in the reporting of gestational trophoblastic neoplasia. Such evidence-based and structured pathology datasets developed through an international effort will facilitate consistent and accurate exchange and comparison of epidemiological and pathologic parameters among different populations and countries. This will ultimately improve gestational trophoblastic neoplasia patient care and facilitate future research.


Persistent Identifierhttp://hdl.handle.net/10722/337464
ISSN
2022 Impact Factor: 2.4
2020 SCImago Journal Rankings: 0.925
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHui, Pei-
dc.contributor.authorWebster, Fleur-
dc.contributor.authorBaergen, Rebecca N-
dc.contributor.authorBuza, Natalia-
dc.contributor.authorCheung, Annie NY-
dc.contributor.authorKaur, Baljeet-
dc.contributor.authorRonnett, Brigitte M-
dc.contributor.authorShih, Ie-Ming-
dc.contributor.authorSeckl, Michael J-
dc.contributor.authorLax, Sigurd F-
dc.contributor.authorMcCluggage, W Glenn-
dc.date.accessioned2024-03-11T10:21:03Z-
dc.date.available2024-03-11T10:21:03Z-
dc.date.issued2022-10-24-
dc.identifier.citationInternational Journal of Gynecological Pathology, 2022, v. 41, n. 6, p. S34-S43-
dc.identifier.issn0277-1691-
dc.identifier.urihttp://hdl.handle.net/10722/337464-
dc.description.abstract<p>Comprehensive pathology reporting of cancers is important for patient management, tumor staging, and prognostication. Standardized cancer datasets are essential in guiding pathology reporting in a consistent and concise manner and this facilitates effective global cancer information exchange and comparison. The International Collaboration on Cancer Reporting (ICCR) is an alliance of several national and international pathology societies in many countries as well as bodies which are involved in tumor classification and staging. One function of the ICCR is to develop evidence-based, standardized reporting datasets for each cancer site. Herein, we report the development of an evidence-based cancer dataset by an ICCR panel of international experts for the reporting of primary uterine gestational trophoblastic neoplasia. We present the core elements that should be included and noncore elements that are recommended for inclusion in pathology reports. Lists of the response values are provided for each element, along with explanatory commentaries. The dataset also discusses controversial issues in the reporting of gestational trophoblastic neoplasia. Such evidence-based and structured pathology datasets developed through an international effort will facilitate consistent and accurate exchange and comparison of epidemiological and pathologic parameters among different populations and countries. This will ultimately improve gestational trophoblastic neoplasia patient care and facilitate future research.</p>-
dc.languageeng-
dc.publisherLippincott, Williams & Wilkins-
dc.relation.ispartofInternational Journal of Gynecological Pathology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectDataset-
dc.subjectGestational trophoblastic neoplasia-
dc.subjectMeasurement-
dc.subjectProtocol-
dc.subjectStaging-
dc.titleDataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)-
dc.typeArticle-
dc.identifier.doi10.1097/PGP.0000000000000876-
dc.identifier.scopuseid_2-s2.0-85140861921-
dc.identifier.volume41-
dc.identifier.issue6-
dc.identifier.spageS34-
dc.identifier.epageS43-
dc.identifier.eissn1538-7151-
dc.identifier.isiWOS:000874872500005-
dc.identifier.issnl0277-1691-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats